We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
(-6.1%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$352M |
| 2 |
Kroger
KR
|
+$279M |
| 3 |
AT&T
T
|
+$235M |
| 4 |
Intel
INTC
|
+$217M |
| 5 |
Edwards Lifesciences
EW
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$461M |
| 2 |
Merck
MRK
|
+$459M |
| 3 |
Coca-Cola
KO
|
+$295M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$283M |
| 5 |
TSMC
TSM
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.08% |
| 2 | Technology | 16.14% |
| 3 | Healthcare | 15.45% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Consumer Staples | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Texas Instruments
TXN
$255B
| $111M | 0.24% |
717,510
+687,546
| +2,295% | +$115M |
|
77
KE Holdings
BEKE
$16.8B
| $110M | 0.24% |
6,270,784
-1,145,232
| -15% | -$18.5M |
|
78
Charles River Laboratories
CRL
$10.9B
| $109M | 0.24% |
555,678
+215,372
| +63% | +$46.5M |
|
79
Citizens Financial Group
CFG
$30.4B
| $108M | 0.24% |
3,150,166
+126,145
| +4% | +$4.67M |
|
80
General Mills
GIS
$19.2B
| $107M | 0.23% |
1,390,307
+278,899
| +25% | +$21.3M |
|
81
CALL
SPDR Gold Trust
GLD
$131B
| $106M | 0.23% |
684,400
-133,100
| -16% | -$21.4M |
|
82
Newmont
NEM
$98.2B
| $105M | 0.23% |
2,488,836
+2,277,063
| +1,075% | +$106M |
|
83
United Rentals
URI
$71.1B
| $104M | 0.23% |
383,652
+4,431
| +1% | +$1.29M |
|
|
SI
84
DELISTED
Silvergate Capital Corporation
SI
| $102M | 0.22% |
1,349,311
+57,732
| +4% | +$4.92M |
|
85
HubSpot
HUBS
$10.5B
| $102M | 0.22% |
375,880
+175,641
| +88% | +$55.8M |
|
86
Xenon Pharmaceuticals
XENE
$6.32B
| $101M | 0.22% |
2,811,095
+820,723
| +41% | +$29.5M |
|
87
AstraZeneca
AZN
$263B
| $98.9M | 0.22% |
901,666
+153,783
| +21% | +$19.5M |
|
88
Qiagen
QGEN
$8.53B
| $98.9M | 0.22% |
2,217,725
+135,652
| +7% | +$6.7M |
|
89
Accenture
ACN
$89.9B
| $98.8M | 0.22% |
383,867
+274,217
| +250% | +$79.2M |
|
90
PUT
iShares Russell 2000 ETF
IWM
$80.9B
| $98.2M | 0.22% |
595,600
+593,600
| +29,680% | +$108M |
|
91
Skyworks Solutions
SWKS
$9.06B
| $97.8M | 0.21% |
1,146,633
-452,869
| -28% | -$46.3M |
|
92
Wells Fargo
WFC
$261B
| $96.5M | 0.21% |
2,399,875
-5,183,384
| -68% | -$223M |
|
93
GlobalFoundries
GFS
$29.4B
| $94.8M | 0.21% |
1,961,265
+1,705,026
| +665% | +$91.8M |
|
94
Trip.com Group
TCOM
$27.5B
| $94.6M | 0.21% |
3,463,775
+2,681,164
| +343% | +$70.2M |
|
95
Trade Desk
TTD
$8.13B
| $94.6M | 0.21% |
1,582,581
+872,505
| +123% | +$49.6M |
|
96
MSCI
MSCI
$40B
| $94.1M | 0.21% |
223,205
+66,777
| +43% | +$30.6M |
|
97
Zoetis
ZTS
$31.6B
| $93.1M | 0.2% |
627,650
+376,546
| +150% | +$62.9M |
|
98
Ulta Beauty
ULTA
$20.4B
| $93.1M | 0.2% |
231,986
+8,829
| +4% | +$3.56M |
|
99
Alexandria Real Estate Equities
ARE
$8.88B
| $92.6M | 0.2% |
660,169
-546,469
| -45% | -$83.9M |
|
100
Constellation Brands
STZ
$22.2B
| $86.9M | 0.19% |
378,465
+343,564
| +984% | +$83.7M |
|
Similar funds
Marshall Wace's Q3 2022 Portfolio in Review
As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.
- Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
- Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
- Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
- Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
- Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
- Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
- Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.
Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.